What Has Been the Progress and Growth of the Transfection Technologies Market in Recent Years?
The transfection technologies market has seen considerable growth due to a variety of factors.
• The market size for transfection technologies has seen significant growth in recent years. Projected to expand from $1.21 billion in 2024 to $1.32 billion in 2025, it boasts a compound annual growth rate (CAGR) of 9.2%.
Factors contributing to this growth during the historical period include increased occurrence of chronic diseases, wider usage of transfection technologies, the rising need for cell & gene therapy, an uptick in R&D investments, and an increase in cases of cancer.
How Does the Forecast Look for the Transfection Technologies Market?
The transfection technologies market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for transfection technologies is projected to experience robust growth in the coming years. The market is set to reach $1.85 billion in 2029, with a compound annual growth rate (CAGR) of 8.9%.
The growth anticipated within the forecast period can be credited to factors such as an increased prevalence of chronic and immunological diseases, the emergent requirement for cell-based therapies, heightened demand for protein production, growing investments and funding into drug delivery systems development, and an upsurge in demand for monoclonal antibodies. Significant trends expected in the forecast period encompass increased research and development in cell-based therapies, adoption of technologically advanced transfection methods, rising demand for advanced therapeutic delivery systems, growing use of dual-reporter assays and co-transfection experiments, and an amplified focus on personalized medicine.
What Are The Leading Drivers Of Growth In The Transfection Technologies Market?
The upward trend in gene therapy is forecasted to stimulate the advancement of the transfection technologies market. The method of gene therapy targets the treatment or prevention of diseases by modifying genes - a procedure that involves inserting, repairing, or replacing defective genes. The growth of gene therapy can be attributed to advancements in genetic research, improved delivery systems, and its potential to cure genetic conditions that were previously deemed incurable. Transfection technologies play a pivotal role in gene therapy, enabling the accurate, secure, and efficient transportation of genetic materials into cells. It caters to both temporary and permanent genome modifications, which are vital for the treatment of genetic disorders and cancers. For example, as indicated in a July 2023 report by the American Society of Gene & Cell Therapy (ASGCT) and Citeline, both US-based organizations, there were 247 gene therapies in Phase II by the end of Q1 of 2023. This figure rose by 5%, reaching 260 by the end of Q2. Therefore, the increase in gene therapy is fostering the expansion of the transfection technologies market.
How Are The Segments Defined Within The Global Transfection Technologies Market?
The transfection technologiesmarket covered in this report is segmented –
1) By Product: Kits And Reagents, Equipment, Other Products
2) By Transfection Method: Lipofection, Electroporation, Nucleofection, Cotransfection, Cationic Lipid Transfection, In-Vivo Transfection, Other Transfection Methods
3) By Application: Virus Production, Protein Production, Gene Silencing, Stem Cell Reprogramming And Differentiation, Stable Cell Line Generation, Therapeutic Delivery, Biomedical Research, Other Applications
4) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Development And Manufacturing Organizations (CDMOs), Academic And Research Institutes, Other End-Users
Subsegments:
1) By Kits And Reagents: Transfection Kits, RNAi Reagents, DNA Reagents, Protein Transfection Reagents
2) By Equipment: Electroporation Devices, Microinjection Equipment, Lipofection Devices, Sonoporation Equipment
3) By Other Products: Transfection Software, Transfection Consumables, Custom Transfection Solutions
Pre-Book The Transfection Technologies Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are Emerging Trends Reshaping The Dynamics Of The Transfection Technologies Market?
Leading organizations in the transfection technologies industry are concentrating on creating innovative technology such as mechanoporation transfection systems. These systems are intended to facilitate sophisticated and tailor-made applications for research and therapeutic processes. Mechanoporation transfection technique generates temporary gaps in cell membranes using mechanical inputs, which enables genetic elements to infiltrate the cells. It is an efficient and minimally aggressive method that sustains superior cell sustainability. For instance, a biotechnology firm from Canada, STEMCELL Technologies, unveiled an advanced transfection system named CellPore in July 2024. This system consists of a benchtop device along with the CellPore Transfection Kit 300 which contains a specially designed reagent set and disposable delivery cartridges. The CellPore system, via controlled and swift distortion in microfluidic channels, successfully infuses cells with small elements, nucleic acids, proteins, and gene alteration complexes, while ensuring negligible cell disruption and superior survival. These qualities play a central role in driving scientific exploration and facilitating the creation of innovative cell and gene treatments.
Who Are the Key Players In The Transfection Technologies Market?
Major companies operating in the transfection technologies market are:
• Thermo Fisher Scientific Inc.
• Lonza Group Ltd.
• Agilent Technologies Inc.
• Sartorius AG
• Revvity Inc.
• Bio-Rad Laboratories Inc.
• QIAGEN N.V.
• Bio-Techne Corp.
• STEMCELL Technologies Inc.
• Promega Corporation
• Takara Bio Inc.
• OriGene Technologies Inc.
• Applied Biological Materials Inc.
• MaxCyte Inc.
• New England Biolabs Inc.
• Cell Signaling Technology Inc.
• System Biosciences LLC
• AMSBIO LLC
• Altogen Biosystems
• OZ Biosciences
• Biontex Laboratories GmbH
• RJH Biosciences Inc.
What Is The Most Dominant Region In The Transfection Technologies Market?
North America was the largest region in the transfection technologies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transfection technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
